RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- (“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel ...
Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
The company’s business grew at a healthy clip, yet its stock price went sideways and its valuation fell. Something has to ...
According to MarketsandMarkets™, the Point of Care Diagnostics Market is projected to grow from about USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at a CAGR of 8.8%.
Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be ...
Full-body MRIs, multi-omics blood tests, continuous glucose monitors, wearable health trackers and advanced biomarker panels ...
According to MarketsandMarkets, the Point of Care Diagnostics Market is projected to grow from about USD 20.63 billion in 2026 to USD 31.46 ...
A read-write wearable both reads your body and writes back to it by delivering an intervention.
For decades, the management of diabetic retinopathy (DR) has consisted mainly of optimizing metabolic control (blood glucose, pressure and lipids) and routine surveillance as preventive strategies, ...
4d
Read-only wearable devices vs. read-write systems: How insulin pumps and more rewrite body signals
Now a new generation of devices is trying to do something the read-only wearable never could, talk back to the body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results